-
Bispecific Antibodies Bring New Progress in Follicular Lymphoma Treatment, New CD79b ADC Drugs Show Significant Value in DLBCL Treatment!
-
Dr. Jun Ma: On the immunotherapeutic progress and future trends for acute lymphoblastic leukemia based on the studies at EHA 2023
-
Dr. Huaqing Wang: Primary Mediastinal B-Cell Lymphoma (PMBCL) Benefits More Significantly from Axi-Cel Treatment
-
Dr. Qian Jiang: Reduced Dosage without Reducing Efficacy, Better Quality of Life for Patients
-
Antimicrobial Susceptibility Testing: The Joint Efforts of CLSI and EUCAST丨ECCMID 2023
-
Interview with Chao Zhuo at ECCMID 2023
-
Dr. Heather-Marie Schmidt: WHO Long-Acting PrEP Guidelines and Priority Actions to End HIV Epidemic in Asia
-
Dr. Iskandar Azwa: Second and Third-Line Treatment Options for HIV/AIDS Patients
-
Dr. Jennifer Hoy: How to Safely Transition ART in HIV Patients Achieving Viral Suppression?
-
Dr. Dong Xu: Meeting More Patient Needs in HIV Health Management
-
Dr. Reena Rajasuriar: Eliminating Regional Disparities to Achieve the 2030 End of HIV Epidemic
-
Dr. Steven Grinspoon: Statin Drugs Can Be Used for Primary Prevention of Cardiovascular Diseases in HIV-Infected Individuals
Connecting Medical Expertise through Media